Status:
COMPLETED
Renal and Bone Outcome After Switching Tenofovir to Different Antiretroviral Strategies
Lead Sponsor:
Asociacion para el Estudio de las Enfermedades Infecciosas
Conditions:
Renal Disease
Eligibility:
All Genders
18+ years
Brief Summary
Renal outcome could be different after switching tenofovir to different antiretroviral strategies, in case of renal toxicity. Therefore, it is necessary to evaluate the importance of renal evolution i...
Detailed Description
Renal toxicity has become an important issue in a large number of HIV infected patients receiving a tenofovir-containing regimen. However, there are no data about the best antiretroviral regimen in pa...
Eligibility Criteria
Inclusion
- HIV-infected patients
- Older than 18 years
- Receiving a Tenofovir-containing regimen, and with criteria of renal toxicity (see above)
- Switching the antiretroviral regimen
Exclusion
- Pregnancy
- Patients receiving prolonged therapy with other nephrotoxic drugs
- Patients not receiving or interrupting antiretroviral regimen
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
245 Patients enrolled
Trial Details
Trial ID
NCT02209740
Start Date
July 1 2014
End Date
December 1 2015
Last Update
December 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Ramon y Cajal
Madrid, Spain, 28034